Vitrolife AB (CHIX:VITRS) Notes Receivable: kr0 Mil (As of Mar. 2026)


CHIX:VITRS Vitrolife AB CHIX:VITRS
80 GF Score
Price kr105.75
GF Value kr163.33
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Vitrolife AB Notes Receivable?

Vitrolife AB CHIX:VITRS 80 Notes Receivable is kr0 Mil as of Mar. 2026. GuruFocus rates CHIX:VITRS with a GF Score™ of 80/100 and a GF Value™ of kr163.33 (Possible Value Trap). The stock has 6 warning signs investors should review.

Vitrolife AB's Notes Receivable for the quarter that ended in Mar. 2026 was kr0 Mil.

Vitrolife AB Notes Receivable Historical Data

* Premium members only.

The historical data trend for Vitrolife AB's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitrolife AB Notes Receivable Chart

Vitrolife AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Vitrolife AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:VITRS
80GF Score
Vitrolife AB CHIX:VITRS
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vitrolife AB Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of kr0 Mil mean?
Vitrolife AB (CHIX:VITRS) has a Notes Receivable of kr0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Vitrolife AB and its competitors.
Is Vitrolife AB's Notes Receivable too high?
Vitrolife AB's current Notes Receivable is kr0 Mil. Overall, Vitrolife AB has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vitrolife AB's Notes Receivable compare to ABT and SYK?
Vitrolife AB's Notes Receivable of kr0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Vitrolife AB and its competitors. Vitrolife AB's current Notes Receivable is kr0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitrolife AB stock overvalued right now?
Based on GuruFocus' analysis, Vitrolife AB (CHIX:VITRS) is currently considered Possible Value Trap. The stock's GF Value™ is kr163.33, compared to a current price of kr105.75 — trading 35.3% below its estimated fair value. The current Notes Receivable is kr0 Mil. Vitrolife AB's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Vitrolife AB (CHIX:VITRS), the current Notes Receivable is kr0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vitrolife AB (CHIX:VITRS) Overvalued in 2026?

Based on GuruFocus' analysis, Vitrolife AB stock appears to be undervalued. The current stock price of kr105.75 is trading 35.3% below its estimated GF Value™ of kr163.33. GuruFocus considers Vitrolife AB to be Possible Value Trap.

Key valuation signals for CHIX:VITRS:

  • Notes Receivable: kr0 Mil
  • GF Value™: kr163.33 vs. price of kr105.75 (35.3% below fair value)
  • GF Score™: 80/100 with 6 warning signs

No single metric tells the full story. See the CHIX:VITRS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vitrolife AB Business Description

Address Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
80GF Score

Get the complete analysis for CHIX:VITRS

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr105.75
Price
kr163.33
GF Value